and data on titration rates and patients stopping or not adhering to therapy, are still not mature. Nevertheless, Mounjaro arrived on the scene with clinical data showing that it was more ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly has benefitted from the windfall from tirzepatide – the active ingredient in its weight loss injection Zepbound and diabetes shot Mounjaro – which targets GLP-1 but also activates ...

Novo Nordisk NVO announced an update to the savings offer for its popular obesity injection, Wegovy (semaglutide). This ...

The launch of Eli Lilly’s diabetes and obesity management drug Mounjaro could be a significant opportunity ... said these medications are started with a low dose, with a titration to higher dose based ...

Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy. Mounjaro is an injectable medication for type 2 diabetes known for its ...